共 227 条
[1]
Xia C(2022)Cancer statistics in China and United States, 2022: profiles, trends, and determinants Chin Med J Engl 135 584-590
[2]
Dong X(2021)Immunotherapy for hepatocellular carcinoma: current status and future prospects Front Immunol 12 765101-1306
[3]
Li H(2021)An SNP reducing SNORD105 and PPAN expression decreases the risk of hepatocellular carcinoma in a Chinese population J Clin Lab Anal 35 e24095-3326
[4]
Cao M(2021)Genetic polymorphisms in CD35 gene contribute to the susceptibility and prognosis of hepatocellular carcinoma Front Oncol 11 700711-5937
[5]
Sun D(2022)ROCK2 polymorphism and expression contribute to increased susceptibility and poor prognosis in hepatocellular carcinoma Int J Gen Med 15 1295-469
[6]
He S(2021)TGF-Β1 & PNPLA3 genetic variants and the risk of hepatic fibrosis and HCC in Egyptian patients with HCV-related liver cirrhosis Asian Pac J Cancer Prev 22 3317-306
[7]
Yang F(2021)Correlations between PNPLA3 gene polymorphisms and NAFLD in type 2 diabetic patients Medicina Kaunas 57 1249-360
[8]
Yan X(2021)Research progress, challenges and perspectives on PNPLA3 and its variants in Liver diseases J Cancer 12 5929-634
[9]
Zhang S(2020)Molecular mechanisms: connections between nonalcoholic fatty liver disease, steatohepatitis and hepatocellular carcinoma Int J Mol Sci 21 1525-463
[10]
Li N(2021)The PNPLA3 rs738409 variant but not MBOAT7 rs641738 is a risk factor for nonalcoholic fatty liver disease in obese U.S. children of hispanic ethnicity Pediatr Gastroenterol Hepatol Nutr 24 455-2053